Posts

Showing posts with the label Blood Testing Market

Blood Testing Market Is Likely To Up Demand At A USD 140.3 Billion By 2028

  San Francisco, 21 May 2021:   The Report  Blood Testing Market  Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin D, ALT, AST, TSH, PSA, Cortisol, Creatinine, BUN, Direct LDL, Testosterone), By Region, And Segment Forecasts, 2021 - 2028 The global blood testing market size is expected to reach USD 140.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.3% from 2021 to 2028. The shortened length of stay at hospitals and reduced contact between patient and concerned physician coupled with the rise in outpatient services have increased the demand for blood testing services. Additionally, the growing prevalence of target diseases such as diabetes, COVID-19, and cardiovascular diseases is expected to drive the market at a significant rate. The preliminary blood testing techniques employed in medical and wellness settings play a crucial role in the management of patient he

Blood Testing Market To Rise At USD 62.9 Billion By 2024 : Grand View Research Inc.

San Francisco, 9 July 2019:   The Report   Blood Testing Market   Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, BUN, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone), By Region, And Segment Forecasts, 2018 – 2024 Global blood testing market is anticipated to reach USD 62.9 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of testing and screening methodologies that enhance near patient diagnosis through enhanced blood testing that reduce diagnostic turnaround times and lower hospitals stay durations is a major factor expected to provide lucrative growth in demand for the market. Federal agencies that play a major role in regulation of genetic tests, including Centers for Medicare and Medicaid Services, Food and Drug Administration, and Federal Trade Commission, have also undertaken initiatives expected to further enhance market usage of Clinical Laboratory Improvement Amendments (CLIA) compliant tests in th